Evidence map›Paper›PMID 30010012›Full record

ArticleThe international journal of biochemistry & cell biology2018

DNMT and HDAC inhibitors together abrogate endotoxemia mediated macrophage death by STAT3-JMJD3 signaling.

Saheli Samanta, Zhigang Zhou, Sheeja Rajasingh, Arunima Panda, Venkatesh Sampath, Johnson Rajasingh

Abstract read
In one paragraph

Article in The international journal of biochemistry & cell biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. The Role of Histone Deacetylases in Acute Lung Injury-Friend or Foe.International journal of molecular sciences · 2023
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Saheli SamantaDepartment of Cardiovascular Medicine, University of Kansas Medical Center, Kansas City, KS, 66160, USA.
Zhigang ZhouDepartment of Cardiovascular Medicine, University of Kansas Medical Center, Kansas City, KS, 66160, USA; Department of Critical Care Medicine, Shanghai General Hospital, Shanghai Jiaotong University, Shanghai, 201620, China.
Sheeja RajasinghDepartment of Cardiovascular Medicine, University of Kansas Medical Center, Kansas City, KS, 66160, USA.
Arunima PandaDepartment of Cardiovascular Medicine, University of Kansas Medical Center, Kansas City, KS, 66160, USA.
Venkatesh SampathDepartment of Pediatrics, Division of Neonatology, Children's Mercy Hospital, Kansas City, MO, USA.
Johnson RajasinghDepartment of Cardiovascular Medicine, University of Kansas Medical Center, Kansas City, KS, 66160, USA; Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS, 66160, USA. Electronic address: rjohnson9@kumc.edu.
University of Kansas Medical Center · USChildren's Mercy Hospital · USShanghai Jiao Tong University · CN

Funding

Transgenic and Gener-Targeting CoreP20GM104936 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SAADI, IRFAN · 2012 to 2016
$10.9M
Inflammatory Angiogenesis in the LungR01HL128374 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI SAMPATH, VENKATESH · 2015 to 2020
$1.8M
Epigenetic modification of endothelial progenitor cells into multipotent cellsR21HL097349 · NHLBI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI JOHNSON, RAJASINGH · 2009 to 2010
$432k
NHLBI NIH HHS R01 HL128374NHLBI NIH HHS R21 HL097349NIGMS NIH HHS P20 GM104936
6 · The paper itself

Abstract

Acute lung injury (ALI) is a common complication of sepsis that often leads to fatal lung disease without effective therapies. It is known that bone marrow derived macrophages are important in resolving the inflammation and maintaining tissue homeostasis. Here, we hypothesize that treatment in combination of DNA methyl transferase inhibitor (DNMTi) 5-Aza 2-deoxycytidine (Aza) and histone deacetylase inhibitor (HDACi) Trichostatin A (TSA) mitigates the inflammation induced pyroptosis and apoptosis during endotoxemia induced ALI. To test this hypothesis, the mice challenged with a sublethal dose of LPS followed by one-hour post-treatment with a single dose of Aza and TSA intraperitoneally showed a substantial attenuation of apoptosis and inflammation. Importantly, we observed significant changes in the mitochondrial membrane structure, and lower levels of DNA fragmentation, reduced expression of apoptotic and pyroptotic genes both transcriptionally and translationally in LPS induced BMDMs treated by a combination of Aza and TSA than in LPS-induced BMDMs treated with either drug alone. The protection was mediated by an inhibition of JNK-ERK and STAT3-JMJD3 activated pathways. Thus, targeting these important signaling pathways with the combination of Aza and TSA would be a good treatment modality for ALI.

Indexed as

AnimalsApoptosisDecitabineDNA (Cytosine-5-)-MethyltransferasesDrug InteractionsEndotoxemiaHistone Deacetylase InhibitorsHydroxamic AcidsJumonji Domain-Containing Histone DemethylasesLungMacrophagesMaleMiceMice, Inbred C57BLMitochondrial MembranesPyroptosisDecitabineDNA (Cytosine-5-)-MethyltransferasesHistone Deacetylase InhibitorsHydroxamic AcidsJumonji Domain-Containing Histone DemethylasesKDM6B protein, humanSTAT3 Transcription Factortrichostatin AAcute lung injuryApoptosisEpigenetic modifiersInflammationJMJD3PyroptosisSTAT3

Identifiers

PMID30010012
PMCPMC6309960
OpenAlexW2883874601

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.